Table 1.
Patient characteristics | n (%) |
Age at diagnosis (yr) | 262 (34) |
Gender | |
Male | 127 (48.5) |
Female | 135 (51.5) |
Extent of the disease | |
Proctitis | 43 (16.4) |
Proctosigmoiditis | 47 (17.9) |
Left-sided colitis | 50 (19.1) |
Pancolitis | 114 (43.5) |
Unknown | 8 (3.0) |
Extraintestinal manifestations | |
Eyes | 2 (0.8) |
Skin | 6 (2.3) |
Joints | 50 (19.1) |
Immunosuppressive therapy | |
Azathioprine | 98 (94.2) |
6-Mercaptopurine | 23 (22.1) |
Infliximab | 36 (34.6) |
Adalimumab | 3 (2.9) |
Golimumab | 1 (1.0) |
Methotrexate | 3 (2.9) |
Miscellaneous | 12 (11.5) |
Reason for IT | |
Steroid-refractory disease course | 40 (38.4) |
Chronic-active disease course | 31 (29.8) |
Steroid-dependent disease course | 27 (26.0) |
Miscellaneous | 6 (5.8) |
IT: Immunosuppressive treatment.